Free Trial

Keefe, Bruyette & Woods Cuts Crescent Capital BDC (NASDAQ:CCAP) Price Target to $18.50

Crescent Capital BDC logo with Finance background

Crescent Capital BDC (NASDAQ:CCAP - Free Report) had its target price cut by Keefe, Bruyette & Woods from $20.00 to $18.50 in a report released on Tuesday,Benzinga reports. They currently have an outperform rating on the stock.

Separately, Wells Fargo & Company reduced their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating for the company in a research note on Friday, February 21st. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $18.90.

View Our Latest Analysis on Crescent Capital BDC

Crescent Capital BDC Stock Down 0.7 %

Shares of Crescent Capital BDC stock traded down $0.10 on Tuesday, hitting $14.51. 168,147 shares of the company traded hands, compared to its average volume of 141,518. Crescent Capital BDC has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The company has a market cap of $537.77 million, a PE ratio of 7.29 and a beta of 0.56. The company has a 50-day moving average price of $17.66 and a 200 day moving average price of $18.53.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The firm had revenue of $46.40 million during the quarter, compared to analysts' expectations of $47.27 million. Sell-side analysts predict that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The company also recently declared a dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were given a $0.05 dividend. The ex-dividend date was Friday, February 28th. Crescent Capital BDC's dividend payout ratio is 84.42%.

Institutional Trading of Crescent Capital BDC

A number of institutional investors and hedge funds have recently modified their holdings of CCAP. HighTower Advisors LLC raised its holdings in Crescent Capital BDC by 0.5% in the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock worth $2,624,000 after acquiring an additional 768 shares during the period. Stifel Financial Corp increased its stake in shares of Crescent Capital BDC by 53.1% in the third quarter. Stifel Financial Corp now owns 66,470 shares of the company's stock worth $1,230,000 after purchasing an additional 23,055 shares during the period. Franklin Resources Inc. lifted its position in shares of Crescent Capital BDC by 35.2% during the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company's stock worth $4,726,000 after purchasing an additional 66,713 shares during the last quarter. Confluence Investment Management LLC lifted its position in shares of Crescent Capital BDC by 0.9% during the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company's stock worth $1,419,000 after purchasing an additional 633 shares during the last quarter. Finally, Redhawk Wealth Advisors Inc. bought a new stake in Crescent Capital BDC during the 4th quarter valued at approximately $659,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines